Journal article icon

Journal article

The changing face of oral anticoagulants

Abstract:

Warfarin has been the established oral anticoagulant for the last 50 years, being effective in the prevention and treatment of venous and arterial thromboembolic disorders. However, the frequent requirement for INR monitoring, multiple drug and food interactions have fuelled the need for development of new oral anticoagulants. Dabigatran is the first of a series of new oral anticoagulants that are emerging as the successors to warfarin. This new group of anticoagulants is rapidly gaining FDA ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/sj.bdj.2013.628

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
RDM Cardiovascular Medicine
Role:
Author
Publisher:
British Dental Association Publisher's website
Journal:
British Dental Journal Journal website
Volume:
215
Issue:
1
Pages:
17-20
Publication date:
2013-07-12
Acceptance date:
2013-05-08
DOI:
EISSN:
1476-5373
ISSN:
0007-0610
Language:
English
Keywords:
Pubs id:
pubs:415737
UUID:
uuid:3e8fbd7b-2dde-4e15-a245-eeb58840fda1
Local pid:
pubs:415737
Source identifiers:
415737
Deposit date:
2013-11-17

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP